Chugai Pharmaceutical (CHGCY) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free CHGCY Stock Alerts $16.00 +0.20 (+1.27%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Chugai Pharmaceutical Short Interest DataCurrent Short Volume2,800 sharesPrevious Short Volume53,000 sharesChange Vs. Previous Month-94.72%Dollar Volume Sold Short$44,352.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares3,289,980,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume57,100 sharesAverage Trading Volume148,905 sharesToday's Volume Vs. Average38% Short Selling Chugai Pharmaceutical ? Sign up to receive the latest short interest report for Chugai Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCHGCY Short Interest Over TimeCHGCY Days to Cover Over TimeCHGCY Percentage of Float Shorted Over Time Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Chugai Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,800 shares $44,352.00 -94.7%N/A0 $15.84 4/15/202453,000 shares $863,370.00 -52.3%N/A0.1 $16.29 3/31/2024111,100 shares $2.13 million +439.3%N/A0.5 $19.13 3/15/202420,600 shares $414,884.00 -17.6%N/A0.2 $20.14 2/29/202425,000 shares $498,000.00 +635.3%N/A0.1 $19.92 2/15/20243,400 shares $65,076.00 -75.0%N/A0 $19.14 Get the Latest News and Ratings for CHGCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chugai Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,500 shares $70,840.00 +40.0%N/A0 $20.24 12/31/20232,500 shares $47,125.00 -89.9%N/A0 $18.85 12/15/202324,800 shares $458,800.00 +140.8%N/A0.2 $18.50 11/30/202310,300 shares $180,765.00 -81.1%N/A0.1 $17.55 11/15/202354,400 shares $844,832.00 +246.5%N/A0.4 $15.53 10/31/202315,700 shares $232,988.00 +481.5%N/A0.1 $14.84 10/15/20232,700 shares $41,796.00 -18.2%N/A0 $15.48 9/30/20233,300 shares $50,787.00 -89.6%N/A0 $15.39 9/15/202331,800 shares $481,770.00 -0.9%N/A0.3 $15.15 8/31/202332,100 shares $489,139.80 +22.5%N/A0.2 $15.24 8/15/202326,200 shares $383,044.00 -21.1%N/A0.1 $14.62 7/31/202333,200 shares $495,676.00 +654.6%N/A0 $14.93 7/15/20234,400 shares $61,204.00 -77.0%N/A0 $13.91 6/30/202319,100 shares $271,984.00 -33.7%N/A0.2 $14.24 6/15/202328,800 shares $425,865.60 -31.6%N/A0.3 $14.79 5/31/202342,100 shares $565,398.79 +109.5%N/A0.3 $13.43 5/15/202320,100 shares $267,631.50 +528.1%N/A0.2 $13.32 4/30/20233,200 shares $41,088.00 -81.8%N/A0 $12.84 4/15/202317,600 shares $218,944.00 +17,500.0%N/A0.1 $12.44 3/31/2023100 shares $1,229.00 -99.3%N/A0 $12.29 3/15/202315,100 shares $184,371.00 -75.7%N/A0.1 $12.21 2/28/202362,000 shares $768,800.00 -39.0%N/A0.3 $12.40 2/15/2023101,700 shares $1.36 million +258.1%N/A0.7 $13.38 1/31/202328,400 shares $366,644.00 -38.4%N/A0.2 $12.91 1/15/202346,100 shares $572,562.00 -22.4%N/A0.1 $12.42 12/30/202259,400 shares $752,598.00 -40.8%N/A0.1 $12.67 12/15/2022100,300 shares $1.28 million +234.3%N/A0.4 $12.76 11/30/202230,000 shares $395,400.00 +689.5%N/A0.2 $13.18 11/15/20223,800 shares $46,892.00 -51.3%N/A0 $12.34 10/31/20227,800 shares $90,012.00 -93.3%N/A0 $11.54 10/15/2022115,900 shares $1.45 million +1,769.4%N/A0.4 $12.52 9/30/20226,200 shares $77,128.00 -43.6%N/A0 $12.44 9/15/202211,000 shares $135,850.00 -86.8%N/A0 $12.35 8/31/202283,100 shares $1.07 million +47.1%N/A0.6 $12.90The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. CHGCY Short Interest - Frequently Asked Questions What is Chugai Pharmaceutical's current short interest? Short interest is the volume of Chugai Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,800 shares of CHGCY short. Learn More on Chugai Pharmaceutical's current short interest. Is Chugai Pharmaceutical's short interest increasing or decreasing? Chugai Pharmaceutical saw a decrease in short interest in April. As of April 30th, there was short interest totaling 2,800 shares, a decrease of 94.7% from the previous total of 53,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Chugai Pharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Chugai Pharmaceutical: Cencora, Inc. (4.88%), McKesson Co. (1.56%), Cardinal Health, Inc. (3.51%), DexCom, Inc. (2.79%), Edwards Lifesciences Co. (1.62%), Moderna, Inc. (6.26%), Lonza Group AG (0.00%), Takeda Pharmaceutical Company Limited (0.20%), IQVIA Holdings Inc. (1.62%), Centene Co. (1.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Chugai Pharmaceutical stock? Short selling CHGCY is an investing strategy that aims to generate trading profit from Chugai Pharmaceutical as its price is falling. CHGCY shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chugai Pharmaceutical? A short squeeze for Chugai Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHGCY, which in turn drives the price of the stock up even further. How often is Chugai Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHGCY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: COR Short Squeeze MCK Short Squeeze CAH Short Squeeze DXCM Short Squeeze EW Short Squeeze MRNA Short Squeeze LZAGY Short Squeeze TAK Short Squeeze IQV Short Squeeze CNC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CHGCY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders